Assignment of Assignor's Interest

Recorded: 2017-09-08 Pages: 4

Assignor

SKOLNICK, BRETT

Executed: 2017-08-23

Assignee

CELGENE INTERNATIONAL II SÀRL

RUE DES MOULINS, COUVET, 2108, SWITZERLAND

Covered Property (1)

Ozanimod Demonstrates Preservation of Brain Volume at 1 and 2 Years in Two Phase 3 Trials of Relapsing Multiple Sclerosis

Application: 62/544,467 →

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.